Posttraumatic Stress Disorder Clinical Trial
Official title:
Optimal Dose of Early Intervention to Prevent PTSD
The overall aim of this study is to determine the optimal dose, 3-session exposure intervention versus 1-session exposure intervention compared to no treatment, for the delivery of exposure therapy in the immediate aftermath of trauma for preventing the development of posttraumatic stress disorder.
The precipitant for adult posttraumatic stress disorder (PTSD) is a known event, which allows
for immediate intervention and presents the potential to prevent the occurrence of this
serious condition. However, there currently are no accepted interventions for the early
intervention and prevention of PTSD in the immediate aftermath of trauma. This study will
determine whether providing exposure therapy to people who have recently experienced trauma
will significantly reduce the severity of PTSD symptoms post-trauma and if delivery of three
exposure sessions will result in larger reductions in the symptoms of PTSD post-trauma than
one exposure session. This study will also examine predictors for treatment response.
Participation in this study will last 12 months. Participants will first undergo an
evaluation session that will include an interview and questionnaires. They will then be
randomly assigned to one of the following three conditions: 1-session exposure therapy,
3-session exposure therapy, or assessment only. Participants receiving 1-session exposure
therapy will complete one treatment session in the emergency department (ED). Participants
receiving 3-session exposure therapy will complete three weekly treatment sessions, with the
first occurring in the ED. Treatment will involve reviewing memories of a recent trauma out
loud with a therapist and audio-recording these discussions for review at home. All
participants will undergo assessments 1, 3, 6, and 12 months after the initial evaluation
session.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03384706 -
A Comparison of CPT Versus ART Versus WL
|
N/A | |
Completed |
NCT03418129 -
Neuromodulatory Treatments for Pain Management in TBI
|
N/A | |
Completed |
NCT03129204 -
Sensation Awareness Focused Training for Spouses
|
N/A | |
Recruiting |
NCT05651295 -
A Precision Medicine Approach to Target Engagement for Emotion Regulation
|
N/A | |
Completed |
NCT05113277 -
Development and Evaluation of a Tonic Immobility Focused Psychoeducational Intervention
|
N/A | |
Recruiting |
NCT05327504 -
Written Exposure Therapy for Veterans With SUD and PTSD
|
N/A | |
Recruiting |
NCT05843695 -
Enhancing Psychotherapy for Veterans and Service Members With PTSD and Anxiety
|
N/A | |
Active, not recruiting |
NCT05530642 -
An Augmented Training Program for Preventing Post-Traumatic Stress Injuries Among Diverse Public Safety Personnel
|
N/A | |
Completed |
NCT00644423 -
Omega-3 Fatty Acids and Post Traumatic Stress Disorder (PTSD)
|
N/A | |
Completed |
NCT02989987 -
NET for SGBV Survivors in Eastern DR Congo
|
N/A | |
Completed |
NCT02320799 -
Randomized Controlled Trial of Interpersonal Psychotherapy for Depression and PTSD Among HIV+ Women in Kenya
|
N/A | |
Recruiting |
NCT02293291 -
Thermal Clinic Treatment in Gulf War Illness
|
Phase 1/Phase 2 | |
Completed |
NCT02242136 -
Treatment of Posttraumatic Stress Disorder and Aggressive Behavior in Soldiers and Ex-combatants
|
N/A | |
Completed |
NCT02720497 -
The Efficacy of 90-Minute Versus 60-Minute Sessions of Prolonged Exposure for PTSD
|
N/A | |
Completed |
NCT01911585 -
Efficacy of 60-minute Versus 90-minute Sessions in Treating PTSD Using Prolonged Exposure
|
N/A | |
Completed |
NCT01693978 -
Contingency Outcomes in Prolonged Exposure
|
N/A | |
Terminated |
NCT01408641 -
Topiramate for Alcohol Use in Posttraumatic Stress Disorder
|
N/A | |
Completed |
NCT01469754 -
Longitudinal Survey Analysis in Lymphoma Survivors
|
N/A | |
Completed |
NCT02362477 -
Telemental Health and Cognitive Processing Therapy for Female Veterans With Military-related PTSD
|
Phase 3 | |
Terminated |
NCT01239173 -
Emotional Memory Reactivation in Posttraumatic Stress Disorder
|
Phase 3 |